• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丹麦 1990-2005 年唾液腺癌:结局和预后因素。丹麦头颈部癌症研究组(DAHANCA)的研究结果。

Salivary gland carcinoma in Denmark 1990-2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA).

机构信息

Department of ENT Head and Neck Surgery, Odense University Hospital, Denmark.

出版信息

Oral Oncol. 2012 Feb;48(2):179-85. doi: 10.1016/j.oraloncology.2011.09.005. Epub 2011 Oct 2.

DOI:10.1016/j.oraloncology.2011.09.005
PMID:21968090
Abstract

To describe outcome and prognostic factors in a national Danish series of patients treated for salivary gland carcinoma. From three Danish nation-wide registries and supplementary patient records, 871 patients diagnosed with primary major or minor salivary gland carcinoma in the period from 1990 to 2005 were identified. A total of 796 (91%) histological specimens were revised according to the WHO 2005 classification. The median follow-up time was 78 months. Three hundred and thirty-four patients (38%) experienced recurrence. Crude survival, disease-specific survival and recurrence-free survival after 5 and 10 years were 66%, 76%, 64% and 51%, 69%, 58%, respectively. In multivariate analysis age, latency, stage, microscopic margins, vascular invasion and histological grade were all independent prognostic factors with regards to crude and disease-specific survival. Stage, microscopic margins, vascular invasion and histological grade were independent prognostic factors for recurrence-free survival. Age over 61 years, latency under 8 months, stage 3+4 disease, involved or close microscopic margins, vascular invasion and high histological grade are all independent prognostic factors with a negative impact on survival in salivary gland carcinoma patients. This knowledge can be helpful in guiding clinicians in daily work and choice of treatment across the large variety of salivary gland carcinoma subtypes.

摘要

描述丹麦全国性唾液腺癌患者治疗的结果和预后因素。从三个丹麦全国性登记处和补充的患者记录中,确定了 1990 年至 2005 年期间诊断为原发性主要或次要涎腺癌的 871 名患者。共有 796 例(91%)组织学标本根据 2005 年世界卫生组织分类进行了修订。中位随访时间为 78 个月。334 例(38%)患者复发。5 年和 10 年后的粗生存率、疾病特异性生存率和无复发生存率分别为 66%、76%、64%和 51%、69%、58%。多变量分析显示,年龄、潜伏期、分期、显微镜下边缘、血管侵犯和组织学分级均为粗生存率和疾病特异性生存率的独立预后因素。分期、显微镜下边缘、血管侵犯和组织学分级是无复发生存率的独立预后因素。年龄>61 岁、潜伏期<8 个月、分期 3+4 期、受累或接近显微镜下边缘、血管侵犯和高组织学分级是所有独立的预后因素,对唾液腺癌患者的生存有负面影响。这些知识有助于指导临床医生在日常工作中根据各种唾液腺癌亚型选择治疗方法。

相似文献

1
Salivary gland carcinoma in Denmark 1990-2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA).丹麦 1990-2005 年唾液腺癌:结局和预后因素。丹麦头颈部癌症研究组(DAHANCA)的研究结果。
Oral Oncol. 2012 Feb;48(2):179-85. doi: 10.1016/j.oraloncology.2011.09.005. Epub 2011 Oct 2.
2
Salivary adenoid cystic carcinoma in Denmark 1990-2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA).1990 - 2005年丹麦涎腺腺样囊性癌:预后及独立预后因素,包括放疗的益处。丹麦头颈癌研究组(DAHANCA)的结果
Oral Oncol. 2015 Dec;51(12):1138-42. doi: 10.1016/j.oraloncology.2015.10.002. Epub 2015 Oct 21.
3
Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.唾液腺癌:局部区域控制、远处转移及总生存的独立预后因素:荷兰头颈肿瘤协作组的结果
Head Neck. 2004 Aug;26(8):681-92; discussion 692-3. doi: 10.1002/hed.10400.
4
Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA).丹麦 1990-2005 年唾液腺癌:一项全国性的发病率、部位和组织学研究。丹麦头颈部癌症研究组(DAHANCA)的研究结果。
Oral Oncol. 2011 Jul;47(7):677-82. doi: 10.1016/j.oraloncology.2011.04.020. Epub 2011 May 25.
5
Management and outcome of recurrent well-differentiated thyroid carcinoma.复发性高分化甲状腺癌的管理与预后
Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819.
6
Salivary duct carcinoma: a Danish national study.涎腺导管癌:一项丹麦全国性研究。
J Oral Pathol Med. 2016 Oct;45(9):664-671. doi: 10.1111/jop.12426. Epub 2016 Jan 29.
7
Salivary gland carcinoma in Denmark: a national update and follow-up on incidence, histology, and outcome.丹麦唾液腺癌:发病率、组织学和预后的国家更新和随访。
Eur Arch Otorhinolaryngol. 2021 Apr;278(4):1179-1188. doi: 10.1007/s00405-020-06205-2. Epub 2020 Jul 20.
8
A predictive nomogram for recurrence of carcinoma of the major salivary glands.大涎腺癌复发的预测列线图。
JAMA Otolaryngol Head Neck Surg. 2013 Jul;139(7):698-705. doi: 10.1001/jamaoto.2013.3347.
9
Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx.口腔和口咽小唾液腺癌患者的预后因素。
Head Neck. 2011 Oct;33(10):1406-12. doi: 10.1002/hed.21641. Epub 2010 Dec 15.
10
Does age affect prognosis in salivary gland carcinoma patients? A national Danish study.年龄对唾液腺癌患者的预后有影响吗?一项丹麦全国性研究。
Acta Oncol. 2016;55 Suppl 1:19-22. doi: 10.3109/0284186X.2015.1114671. Epub 2016 Jan 11.

引用本文的文献

1
A novel postoperative nomogram and risk classification system for individualized estimation of survival among patients with parotid gland carcinoma after surgery.一种新型的术后列线图和风险分类系统,用于个体化评估手术后腮腺癌患者的生存情况。
J Cancer Res Clin Oncol. 2023 Nov;149(16):15127-15141. doi: 10.1007/s00432-023-05303-y. Epub 2023 Aug 26.
2
Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma.维甲酸受体/视黄酸 X 受体信号转导的反向激动剂作为针对人腺样囊性癌的谱系特异性抗肿瘤药物。
J Natl Cancer Inst. 2023 Jul 6;115(7):838-852. doi: 10.1093/jnci/djad062.
3
Prognostic risk factor of major salivary gland carcinomas and survival prediction model based on random survival forests.
基于随机生存森林的大唾液腺癌预后风险因素和生存预测模型。
Cancer Med. 2023 May;12(9):10899-10907. doi: 10.1002/cam4.5801. Epub 2023 Mar 19.
4
Histopathological Aspects of the Prognostic Factors for Salivary Gland Cancers.涎腺癌预后因素的组织病理学方面
Cancers (Basel). 2023 Feb 15;15(4):1236. doi: 10.3390/cancers15041236.
5
[Salivary gland carcinomas - Monocentric experience on subtypes and their incidences over 42 years].[唾液腺癌——42年单中心关于亚型及其发病率的经验]
Laryngorhinootologie. 2023 Jul;102(7):512-520. doi: 10.1055/a-1976-9694. Epub 2022 Dec 21.
6
Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period.20 年来波兰最常见腮腺癌的临床流行病学分析。
Int J Environ Res Public Health. 2022 Aug 18;19(16):10247. doi: 10.3390/ijerph191610247.
7
Prediction of Long-Term Survival Outcome by Lymph Node Ratio in Patients of Parotid Gland Cancer: A Retrospective study.腮腺癌患者淋巴结比率对长期生存结果的预测:一项回顾性研究。
Front Surg. 2022 May 11;9:903576. doi: 10.3389/fsurg.2022.903576. eCollection 2022.
8
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review.评估复发性涎腺癌挽救性手术后的生存情况:系统评价。
Head Neck. 2022 Aug;44(8):1961-1975. doi: 10.1002/hed.27062. Epub 2022 Apr 20.
9
A Parsimonious Prognostic Model and Heat Map for Predicting Survival Following Adjuvant Radiotherapy in Parotid Gland Carcinoma With Lymph Node Metastasis.具有淋巴结转移的腮腺癌患者接受辅助放疗后生存预测的简约预后模型和热图
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211035257. doi: 10.1177/15330338211035257.
10
Patterns of care, toxicity and outcome in the treatment of salivary gland carcinomas: long-term experience from a tertiary cancer center.治疗涎腺癌的护理模式、毒性和结局:来自三级癌症中心的长期经验。
Eur Arch Otorhinolaryngol. 2021 Nov;278(11):4411-4421. doi: 10.1007/s00405-021-06652-5. Epub 2021 Mar 24.